Begin main content

Positron Emission Tomography–Computed Tomography for Neurological Indications: Diagnostic Accuracy, Clinical Utility, Cost-Effectiveness, and Guidelines

Last updated: August 21, 2018
Project Number: RB1245-000
Product Line: Rapid Response
Research Type: Other Diagnostics
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the diagnostic test accuracy of PET-CT in patients with medically refractory epileptic seizures, multiple sclerosis, or dementia?
  2. What is the clinical utility of PET-CT in patients with medically refractory epileptic seizures, multiple sclerosis, or dementia?
  3. What is the cost-effectiveness of PET-CT in patients with medically refractory epileptic seizures, multiple sclerosis, or dementia?
  4. What are the evidence-based guidelines regarding the use of PET-CT in patients with medically refractory epileptic seizures, multiple sclerosis, or dementia?

Key Message

One non-randomized study was identified regarding positron emission tomographycomputed tomography (PET-CT) in patients with dementia. In addition, one evidence-based guideline was identified regarding the use of PET-CT in patients with dementia.